-
Most Popular

Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.

The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
Why Is Axcella Health (AXLA) Stock Down 21% Today?
Axcella Health (AXLA) stock is falling on Thursday following a rally from its announcement of a new Covid-19 treatment patent.
Why Is Acer Therapeutics (ACER) Stock Up 85% Today?
Acer Therapeutics (ACER) stock is taking off on Thursday after the company announced an acquisition deal with Zevra Therapeutics (ZVRA).
Why Is NanoVibronix (NAOV) Up 153% Today?
NanoVibronix (NAOV) stock is climbing higher on Wednesday after releasing independent results from a study of its UroShield medical device.
Why Is Outlook Therapeutics (OTLK) Stock Down 78% Today?
Outlook Therapeutics (OTLK) stock is taking a beating on Wednesday after getting a rejection letter from the FDA for its wet AMD treatment..
Why Is Axcella Health (AXLA) Stock Up 280% Today?
Axcella Health is surging today on news that it has patented a new long Covid-19 treatment. Here's what this means for AXLA stock.
Apellis Layoffs 2023: What to Know About the Latest APLS Job Cuts
Apellis Pharmaceuticals (APLS) layoffs are a hot topic on Tuesday as the commercial-stage biopharmaceutical company prepares for job cuts.
Why Is TC BioPharm (TCBP) Stock Up Today?
TC BioPharm (TCBP) stock is up on Tuesday after the clinical-stage biopharmaceutical company announced an upcoming presentation.
Why Is Novocure (NVCR) Stock Down 30% Today?
Following Novocure’s disappointing late-stage clinical trial for its cancer-treating platform, NVCR stock stumbled on relevancy concerns.
Why Is Myomo (MYO) Stock Down 13% Today?
Myomo (MYO) stock is dropping on Monday after the wearable medical robotics company priced a $4.4 million public share offering.
Why Is YS Biopharma (YS) Stock Up 71% Today?
YS Biopharma (YS) stock is rising higher on Friday after the biopharmaceutical company announced officers purchasing shares.